Alcohol Abuse

Overview

Alcohol abuse encompasses a range of conditions including Alcoholism, Alcohol Use Disorder (AUD), Alcohol Dependence, and Binge Drinking. These conditions are characterized by excessive or uncontrolled consumption of alcohol, leading to significant health, social, and psychological consequences.

• Alcoholism: Chronic disease involving uncontrollable drinking and preoccupation with alcohol.

• Alcohol Use Disorder (AUD): Maladaptive patterns for problematic drinking causing distress or harm.

• Alcohol Dependence: Physical or psychological reliance on alcohol.

• Binge Drinking: Consuming five or more drinks (men) or four or more drinks (women) in about 2 hours.

• Measurement: Blood alcohol concentration (BAC) is used to gauge intoxication.

Standard Drink Equivalents

Understanding standard drink sizes is essential for assessing alcohol intake and risk.

Statistics and Prevalence

• Alcohol abuse is widespread in the United States, with significant public health implications.

• In 2020, 28.8% of adults reported binge drinking at least once in the past month.

• 27.5% of people aged 18+ reported binge drinking in the past month.

Pathophysiology and Etiology

Mechanisms of Alcohol Action

Alcohol acts as a CNS depressant, primarily affecting neurotransmitter systems and metabolic pathways.

• Gamma-aminobutyric acid (GABA): Alcohol enhances GABA activity, leading to sedation and drowsiness.

• Glutamate: Alcohol decreases glutamate activity, impairing cognition and motor functions.

• Metabolism: Alcohol is metabolized in the liver, primarily by alcohol dehydrogenase and aldehyde dehydrogenase.

Risk Factors

• Genetic and Biological Factors: Family history increases risk.

• Cultural Influences: Social norms and environment.

• Mental and Substance Use Disorders: Comorbid psychiatric conditions increase vulnerability.

Clinical Manifestations

• Effects of Alcohol Use: Health risks increase when alcohol use is moderate/high; excessive use leads to significant health consequences.

• Intoxication: Drowsiness, slurred speech, impaired judgment.

• Life-Threatening Conditions: Risk of overdose, organ damage, and death.

Intoxication and Overdose

Chronic Use and Complications

Long-Term Effects

• Liver Disease: Cirrhosis, fatty liver, hepatitis.

• Myocardial Disease: Alcoholic cardiomyopathy.

• Esophageal Conditions: Inflammation and erosion of stomach lining.

• Pancreatitis: Inflammation of the pancreas.

• Cancers: Increased risk of oral, esophageal, liver, and breast cancer.

• Neurological Impairment: Thiamine (B1) deficiency, Wernicke-Korsakoff syndrome.

• Psychiatric Disorders: Depression, cognitive impairment.

Wernicke-Korsakoff Syndrome (WKS)

WKS is a severe neurological disorder associated with chronic alcohol use and thiamine deficiency, characterized by confusion, ataxia, and ophthalmoplegia. Korsakoff syndrome involves memory loss, confabulation, and learning deficits.

• Treatment: IV thiamine replacement, supportive care.

Alcohol Withdrawal Syndromes

Alcohol Withdrawal Syndrome

Withdrawal symptoms begin 6-24 hours after last drink and may resolve within 1-2 days, but can progress to severe complications.

• Agitation, anxiety, autonomic reactions (sweating, tremors)

• Hallucinations, hypertension, tachycardia, fever

• Severe: Alcohol withdrawal hallucinosis, withdrawal seizures, delirium tremens

Alcohol Withdrawal Delirium (Delirium Tremens, DTs)

• Occurs on days 2-3, can appear up to 14 days after last drink.

• Symptoms: Disorientation, confusion, autonomic instability, uncontrolled shaking, hypertension.

• High risk of severe outcomes: Arrhythmias, death.

Diagnostic Tests

• Blood Alcohol Level (BAL) Measurement: Breathalyzer, laboratory measurement.

• High-risk: BAL > 0.3% with withdrawal symptoms suggests physical dependence.

Treatment of Withdrawal

• First Line Treatment: Benzodiazepines (Chlordiazepoxide, Diazepam, Lorazepam, Chlorazepate).

• Treatment Approaches: Symptom-triggered or combination therapy; adjuncts include antipsychotics, thiamine, folate, magnesium.

• Determining Treatment: Based on withdrawal severity, medical history, mental status, vital signs.

• Symptom Control and Supportive Care: Ambulatory or inpatient detox; supplement with thiamine, multivitamins, folate.

Pharmacological Management

Disulfiram (Antabuse)

• Classification: Alcohol abuse therapy adjunct.

• Action: Inhibits aldehyde dehydrogenase, causing unpleasant reactions if alcohol is consumed (flushing, nausea, palpitations).

• Therapeutic Effect: Promotes abstinence via aversion therapy.

• Dosage: 100-500 mg daily for 7-14 weeks, then 250 mg daily (up to 500 mg).

• Adverse Effects: Drowsiness, fatigue, headache, metallic taste, erectile dysfunction.

Nursing Considerations

• Monitor for severe reactions (respiratory depression, arrhythmias, MI, CHF, death).

• Assess for concurrent ETOH and disulfiram use; avoid recent alcohol ingestion.

Patient/Family Teaching

• Report adverse reactions and consequences of drinking alcohol during treatment.

• Avoid alcohol-containing products (mouthwash, cough syrup, etc.).

• Common adverse effects: drowsiness, fatigue, headache, metallic taste, visual changes, severe stomach pain.

Naltrexone (ReVia, Vivitrol)

• Classification: Alcohol abuse therapy adjunct.

• Action: Blocks opioid receptors, reducing the rewarding effects of alcohol and cravings.

• Therapeutic Effect: Reduces alcohol dependence and relapse.

• Dosage: 50 mg daily, IM monthly.

• Adverse Effects: Nausea, headache, dizziness, malaise, decreased appetite, abdominal pain, anxiety, insomnia, liver failure.

Acamprosate (Campral)

• Classification: Delivered via enteric coated tablets.

• Action: Decreases cravings and withdrawal symptoms.

Lifespan Considerations

• Adolescents: Increased risk for long-term cognitive and developmental effects.

• Women: Higher risk for liver damage and cardiovascular effects at lower doses.

• Pregnant Women: Risk of fetal alcohol spectrum disorders.

• Older Adults: Increased sensitivity to alcohol and risk if comorbidities.

Nursing Process

• Assessment: Evaluate substance use, medical history, and comorbidities.

• Diagnosis: Identify alcohol-related disorders and complications.

• Goals/Planning: Promote abstinence, safety, and recovery.

• Implementation: Provide symptom control during withdrawal.

• Evaluation: Monitor progress and adjust care as needed.

Key Equations and Concepts

• Blood Alcohol Concentration (BAC):

where r = the distribution ratio (0.68 for men, 0.55 for women).

Example: If a male weighing 70 kg consumes 40 g of alcohol:

Additional info: Actual BAC calculation is an estimate; actual BAC depends on metabolism, food intake, and other factors.